The global oligonucleotides market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing demand for DNA and RNA oligos in research and diagnostics applications. The pharmaceutical application segment accounted for the largest share of the global oligonucleotides market in 2018, followed by research and diagnostic applications.
DNA Oligos accounted for the largest share of the global oligonucleotides market in 2018, followed by RNA Oligos. The DNA Oligo segment is expected to maintain its dominance throughout the forecast period due to its wide range of applications such as gene editing, gene therapy, genetic testing and others.
-The market for oligonucleotides is expected to grow as more people are diagnosed with cancer and HIV.
-There is a lack of competition in the oligonucleotide drug market which will lead to higher prices for these drugs.
Industry Growth Insights published a new data on “Oligonucleotides Market”. The research report is titled “Oligonucleotides Market research by Types (DNA Oligos, RNA Oligos), By Applications (Pharmaceutical, Research, Diagnostic), By Players/Companies Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, GenScript, BBI Life Sciences, GeneDesign, TriLink BioTechnologies, SGS DNA, LC Sciences, Twist Bioscience, Creative Biogene, General Biosystems”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oligonucleotides Market Research Report
By Type
DNA Oligos, RNA Oligos
By Application
Pharmaceutical, Research, Diagnostic
By Companies
Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, GenScript, BBI Life Sciences, GeneDesign, TriLink BioTechnologies, SGS DNA, LC Sciences, Twist Bioscience, Creative Biogene, General Biosystems
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Oligonucleotides Market Report Segments:
The global Oligonucleotides market is segmented on the basis of:
Types
DNA Oligos, RNA Oligos
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical, Research, Diagnostic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Integrated DNA Technologies
- Agilent
- Sigma-aldrich
- Eurofins Genomics
- L.G.C Biosearch Technologies
- Eurogentec S.A
- Nitto Denko Avecia Inc
- GenScript
- BBI Life Sciences
- GeneDesign
- TriLink BioTechnologies
- SGS DNA
- LC Sciences
- Twist Bioscience
- Creative Biogene
- General Biosystems
Highlights of The Oligonucleotides Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA Oligos
- RNA Oligos
- By Application:
- Pharmaceutical
- Research
- Diagnostic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oligonucleotides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oligonucleotides are short pieces of DNA or RNA.
Some of the major companies in the oligonucleotides market are Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, GenScript, BBI Life Sciences, GeneDesign, TriLink BioTechnologies, SGS DNA, LC Sciences, Twist Bioscience, Creative Biogene, General Biosystems.
The oligonucleotides market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oligonucleotides Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oligonucleotides Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oligonucleotides Market - Supply Chain
4.5. Global Oligonucleotides Market Forecast
4.5.1. Oligonucleotides Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oligonucleotides Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oligonucleotides Market Absolute $ Opportunity
5. Global Oligonucleotides Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oligonucleotides Market Size and Volume Forecast by Type
5.3.1. DNA Oligos
5.3.2. RNA Oligos
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oligonucleotides Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oligonucleotides Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical
6.3.2. Research
6.3.3. Diagnostic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oligonucleotides Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oligonucleotides Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oligonucleotides Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oligonucleotides Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oligonucleotides Demand Share Forecast, 2019-2026
9. North America Oligonucleotides Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oligonucleotides Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oligonucleotides Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical
9.4.2. Research
9.4.3. Diagnostic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oligonucleotides Market Size and Volume Forecast by Type
9.7.1. DNA Oligos
9.7.2. RNA Oligos
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oligonucleotides Demand Share Forecast, 2019-2026
10. Latin America Oligonucleotides Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oligonucleotides Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oligonucleotides Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical
10.4.2. Research
10.4.3. Diagnostic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oligonucleotides Market Size and Volume Forecast by Type
10.7.1. DNA Oligos
10.7.2. RNA Oligos
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oligonucleotides Demand Share Forecast, 2019-2026
11. Europe Oligonucleotides Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oligonucleotides Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oligonucleotides Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical
11.4.2. Research
11.4.3. Diagnostic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oligonucleotides Market Size and Volume Forecast by Type
11.7.1. DNA Oligos
11.7.2. RNA Oligos
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
1.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oligonucleotides Demand Share, 2019-2026
12. Asia Pacific Oligonucleotides Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oligonucleotides Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oligonucleotides Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical
12.4.2. Research
12.4.3. Diagnostic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oligonucleotides Market Size and Volume Forecast by Type
12.7.1. DNA Oligos
12.7.2. RNA Oligos
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oligonucleotides Demand Share, 2019-2026
13. Middle East & Africa Oligonucleotides Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oligonucleotides Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oligonucleotides Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical
13.4.2. Research
13.4.3. Diagnostic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oligonucleotides Market Size and Volume Forecast by Type
13.7.1. DNA Oligos
13.7.2. RNA Oligos
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oligonucleotides Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oligonucleotides Market: Market Share Analysis
14.2. Oligonucleotides Distributors and Customers
14.3. Oligonucleotides Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Integrated DNA Technologies
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Agilent
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sigma-aldrich
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Eurofins Genomics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. L.G.C Biosearch Technologies
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Eurogentec S.A
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Nitto Denko Avecia Inc
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GenScript
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BBI Life Sciences
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. GeneDesign
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. TriLink BioTechnologies
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. SGS DNA
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. LC Sciences
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Twist Bioscience
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Creative Biogene
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. General Biosystems
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
